News & Perspective

Apr 29, 2014

Apr 29, 2014

News Scan for Apr 29, 2014

More Ebola cases in Guinea
Youth anthrax guidance
Food safety funding

Oct 10, 2012

Oct 10, 2012

Changes in select agent rules concern public health labs

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

Jun 15, 2011

Jun 15, 2011

Panel calls for refining, paring select-agent list

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

Oct 08, 2008

Oct 08, 2008

Two firms win NIAID support for Ebola-Marburg vaccines

(CIDRAP News) – Two biotechnology companies—Crucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.—recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.

Dec 11, 2006

Dec 11, 2006

CDC rates hospital bioterrorism preparedness

(CIDRAP News) – Soon after the terrorist attacks of 2001, Congress approved emergency funds to teach hospital staffs how to recognize and respond to bioterrorism attacks, and today the US Centers for Disease Control and Prevention (CDC) released its first report on those efforts.

Jun 11, 2004

Jun 11, 2004

CDC issues bioterrorism-response guidebook for coroners

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has published a guidebook to help medical examiners and coroners detect and respond to bioterrorism.

Nov 18, 2003

Nov 18, 2003

NIH launches first human trial of Ebola vaccine

(CIDRAP News) – The National Institutes of Health (NIH) today announced the start of the first human trial of a vaccine for Ebola virus infection, a currently untreatable disease that kills most of its victims.

Pages

Sort Results

 

Narrow results

by Topic

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»